What's new

EMEA-002042-PIP03-23

EMEA-002042-PIP03-23

Jun 6, 2025 - 16:20
 0
EMEA-002042-PIP03-23
EMEA-002042-PIP03-23
Read More

Tags:

Previous Article

Opinion/decision on a Paediatric investigation plan (PIP): Ztalmy, Ganaxolone, d...

Next Article

EMEA-001039-PIP04-23

Related Posts

Human medicines European public assessment report (EPAR): Ztalmy, ganaxolone, Date of authorisation: 26/07/2023, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR...

Jun 5, 2025  0

Management Board meeting: 13 March 2025, European Medicines Agency, Amsterdam, the Netherlands, 13 March 2025

Management Board meeting: 13 March 2025, European Medic...

May 23, 2025  0

Human medicines European public assessment report (EPAR): Faslodex, fulvestrant, Date of authorisation: 09/03/2004, Revision: 26, Status: Authorised

Human medicines European public assessment report (EPAR...

May 15, 2025  0